Astera Labs, Inc. ALAB
We take great care to ensure that the data presented and summarized in this overview for Astera Labs, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ALAB
Top Purchases
Top Sells
About ALAB
Insider Transactions at ALAB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 03
2025
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
37,000
-0.36%
|
$2,109,000
$57.64 P/Share
|
|
Apr 02
2025
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
63,000
-0.43%
|
$3,906,000
$62.83 P/Share
|
|
Mar 03
2025
|
Jitendra Mohan Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-1.48%
|
$5,325,000
$71.37 P/Share
|
|
Mar 02
2025
|
Craig H Barratt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,637
+50.0%
|
-
|
|
Feb 27
2025
|
Michael Truett Tate Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
125,800
-10.11%
|
-
|
|
Feb 26
2025
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
125,800
-100.0%
|
$10,315,600
$82.53 P/Share
|
|
Feb 26
2025
|
Michael Truett Tate Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
125,800
+50.0%
|
-
|
|
Feb 26
2025
|
Michael Truett Tate Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
125,800
-9.18%
|
-
|
|
Feb 20
2025
|
Philip Mazzara General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
50,000
-4.51%
|
$4,350,000
$87.61 P/Share
|
|
Feb 19
2025
|
Jitendra Mohan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
350,680
-2.26%
|
$31,561,200
$90.26 P/Share
|
|
Feb 19
2025
|
Sanjay Gajendra Director |
SELL
Open market or private sale
|
Direct |
350,680
-2.26%
|
$31,561,200
$90.26 P/Share
|
|
Feb 18
2025
|
Philip Mazzara General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
7,536
-3.03%
|
$693,312
$92.07 P/Share
|
|
Feb 18
2025
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
34,474
-12.37%
|
$3,171,608
$92.07 P/Share
|
|
Feb 18
2025
|
Jack R Lazar Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.83%
|
$455,000
$91.63 P/Share
|
|
Feb 18
2025
|
Michael E. Hurlston Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.54%
|
$227,500
$91.75 P/Share
|
|
Dec 11
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
50,000
-1.19%
|
-
|
|
Dec 04
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
16,000
-0.19%
|
$1,888,000
$118.08 P/Share
|
|
Dec 04
2024
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
11,000
-0.15%
|
$1,298,000
$118.18 P/Share
|
|
Dec 03
2024
|
Manuel Alba Director |
SELL
Open market or private sale
|
Indirect |
63,000
-0.24%
|
$6,993,000
$111.57 P/Share
|
|
Dec 03
2024
|
Michael Truett Tate Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
167,000
-0.91%
|
$18,537,000
$111.86 P/Share
|
Last 12 Months Summary
Buy / Acquisition
1.33M
Shares
From
7
Insiders
| Grant, award, or other acquisition | 110K shares |
|---|---|
| Exercise of conversion of derivative security | 40K shares |
| Bona fide gift | 1.16M shares |
| Other acquisition or disposition | 23.8K shares |
Sell / Disposition
11.4M
Shares
From
13
Insiders
| Open market or private sale | 4.44M shares |
|---|---|
| Other acquisition or disposition | 5.61M shares |
| Bona fide gift | 1.35M shares |